Swiss healthcare startup Vtuls, which uses AI and machine-learning technologies to remotely monitor vital signs, has signed an agreement with Swiss chronic disease specialty pharmacy MediService to serve home-care patients.
The partnership will see Vtuls’ Remote Patient Monitoring solution deployed on the MediService network within the framework of a trial, allowing nurses and physicians to remotely monitor their patients with an improved home care service.
Vtuls’ solution tracks key vital signs, including blood pressure, blood oxygen, and heart rate to monitor overall patient health status.
The platform has been designed to be easy to use by elderly or vulnerable people and deliver accurate vital signs readings by a patient looking into their smartphone’s built-in camera for 40 seconds.
Results are stored and delivered to physicians via the purpose-built Vtuls mobile app.
MediService, a company of the Galenica Group, will pilot Vtuls’ technology across its network, giving healthcare providers new tools to monitor patients with severe medical conditions in the home environment.
The technology has been designed to minimise the need for unnecessary and potentially risky hospital consultations.
What’s more, it will support providers in making decisions regarding the need for future medication and treatment by tracking the rate of deterioration to anticipate future needs.
Dr Robert Kelly, chief medical officer at Vtuls, said: “Our AI-supported, connected home care not only ensures patients remain well cared for at home, it also reduces the resources required and substantially lowers cost of monitoring.
“It’s also more efficient and the data easier to track. We are delighted to be partnering with MediService, the leading healthcare provider in Switzerland. Together, we look forward to transforming home care.”
